share_log

Weak Statutory Earnings May Not Tell The Whole Story For Shanghai Titan Scientific (SHSE:688133)

Weak Statutory Earnings May Not Tell The Whole Story For Shanghai Titan Scientific (SHSE:688133)

《弱法定收益可能无法完全反映上海泰坦科学(SHSE:688133)的整体情况》
Simply Wall St ·  11/07 08:09

Shanghai Titan Scientific Co., Ltd.'s (SHSE:688133) recent weak earnings report didn't cause a big stock movement. However, we believe that investors should be aware of some underlying factors which may be of concern.

上海泰坦科学股份有限公司(SHSE:688133)近期的表现疲弱并没有引起股价大幅波动。然而,我们认为投资者应该注意一些潜在的令人担忧的因素。

big
SHSE:688133 Earnings and Revenue History November 7th 2024
SHSE:688133盈利和营业收入历史2024年11月7日

How Do Unusual Items Influence Profit?

非常规项目如何影响利润?

To properly understand Shanghai Titan Scientific's profit results, we need to consider the CN¥20m gain attributed to unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. Shanghai Titan Scientific had a rather significant contribution from unusual items relative to its profit to September 2024. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

要正确理解上海泰坦科学的利润结果,我们需要考虑到归因于飞凡项目的2000万人民币收益。虽然获得更高利润总是好事,但有时来自飞凡项目的大额贡献会抑制我们的热情。当我们对成千上万家上市公司的数据进行分析时,发现在某一年来自飞凡项目的增长往往不会在下一年重复。这并不奇怪,考虑到其名字。相对于2024年9月的利润,上海泰坦科学的飞凡项目贡献相当显著。其他条件相等的情况下,这可能会导致法定利润对潜在盈利能力的指引效果较差。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

这可能会让您想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看基于其估计的未来盈利能力的互动图表。

Our Take On Shanghai Titan Scientific's Profit Performance

我们对上海泰坦科学的利润表现看法

As we discussed above, we think the significant positive unusual item makes Shanghai Titan Scientific's earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Shanghai Titan Scientific's underlying earnings power is lower than its statutory profit. In further bad news, its earnings per share decreased in the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you want to do dive deeper into Shanghai Titan Scientific, you'd also look into what risks it is currently facing. While conducting our analysis, we found that Shanghai Titan Scientific has 3 warning signs and it would be unwise to ignore them.

正如我们之前讨论的,我们认为显著积极的飞凡项目使上海泰坦科学的收益不适合作为其潜在盈利能力的参考。因此,我们认为很可能上海泰坦科学的潜在盈利能力低于其法定利润。更令人担忧的是,其每股收益在过去一年有所下降。归根结底,要全面了解公司,重要的不仅仅是上述因素。如果想要深入了解上海泰坦科学,还应该研究它目前面临的风险。在进行分析时,我们发现上海泰坦科学有3个警示信号,忽视它们是不明智的。

This note has only looked at a single factor that sheds light on the nature of Shanghai Titan Scientific's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

这则公告只关注了一个揭示上海泰坦科学利润性质的因素。但是还有许多其他方式可以帮助你了解一家公司。有些人认为股本回报率高是一家优质业务的良好标志。虽然可能需要您做一些研究,但您可能会发现这个提供了高股本回报率公司收藏的免费收藏,或者这个内部人士持股大的股票名单会很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发